Dr Reddy’s Labs gets USFDA nod for generic Librax capsules

Chlordiazepoxide hydrochloride and clidinium bromide capsules approved by USFDA

86
Dr Reddy's

Last Updated on September 3, 2021 by The Health Master

Dr. Reddy’s Laboratories Ltd announced the launch of chlordiazepoxide hydrochloride and clidinium bromide capsules USP, 5 mg/2.5 mg.

It is a therapeutic equivalent generic version of Librax (chlordiazepoxide hydrochloride and clidinium bromide) approved by the US Food and Drug Administration (USFDA).

Dr Reddy’s chlordiazepoxide hydrochloride and clidinium bromide capsules USP are available in one strength of 5 mg/2.5 mg capsules in bottle count sizes of 100.

The Librax brand and generic market had US sales of approximately $105.9 million MAT for the most recent twelve months ending in July 2021 according to IQVIA Health.

Granules India gets Health Canada nod for drug for Arthritis pain

Sun Pharma gets exclusive right for Winlevi acne cream in US,…

Aurobindo Pharma gets USFDA nod for cancer treatment drug

USFDA approves drug for severe Itching in kidney disease patients

Zydus Cadila gets USFDA nod for Tofacitinib ER Tablets

GSK gets USFDA nod for Jemperli to treat advanced solid Tumours

7 Benefits of including FACE MIST in your Skincare Regime

Johnson & Johnson’s HIV vaccine fails mid-stage study

FDC: Fixed Dose Combinations are beneficial in heart diseases: Study

Sun Pharma gets exclusive right for Winlevi acne cream in US,…

Granules India gets Health Canada nod for drug for Arthritis pain

Latest Notifications regarding Pharmaceuticals

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner